pomalidomide has been researched along with HTLV-I Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, A; Ishizawa, M; Kannagi, M; Katagiri, K; Kondo, N; Masuda, T; Nagano, Y; Yoneda, T | 1 |
1 other study(ies) available for pomalidomide and HTLV-I Infections
| Article | Year |
|---|---|
Involvement of EZH2 inhibition in lenalidomide and pomalidomide-mediated growth suppression in HTLV-1-infected cells.
Topics: Antiviral Agents; Cell Line; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Lenalidomide; Microbial Sensitivity Tests; Thalidomide | 2021 |